Stock Analysis·← Pickers

HSCS

HeartSciences Inc.

HeartSciences Inc. (HSCS) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 52.7, with 1/3 trend checks passing.

Price
$2.56
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
52.7
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

HSCS with MA50 and MA200

3.853.302.762.211.6707/3110/2401/2204/1707/15
HSCS2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$2.17+18.02% vs price
MA200
$2.66-3.88% vs price
RSI (14)
52.7Neutral zone
MACD Signal
BearishMomentum below signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for HSCS

HeartSciences Inc. (HSCS) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $2.56, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 18.0% and below the 200-day moving average by 3.9%.

Momentum and stretch context

HSCS currently has an RSI reading of 52.7, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

This page is designed to help you quickly understand what the HSCS chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About HeartSciences Inc.

HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process. Among its offerings is the MyoVista wavECG device, a 12-lead resting ECG that provides comprehensive diagnostic information concerning cardiac function alongside conventional ECG data in a single examination. Furthermore, the company offers MyoVista Insights, a cloud-based platform capable of hosting its AI-ECG algorithms across various ECG hardware systems. Established in 2007, HeartSciences Inc. operates from its headquarters in Southlake, Texas. The company was formerly named Heart Test Laboratories, Inc. until its rebranding to HeartSciences Inc. in October 2024.

Sector
Healthcare
Industry
Medical - Devices
CEO
Andrew Simpson
Employees
15
Market cap
$5.5M
Beta
1.79
52-week range
$1.63 – $4.30
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
16 Jun 2022
ISIN
US42254E3027
CUSIP
42254E302
Company profile data from Financial Modeling Prep. HSCS listed on NASDAQ.
Share dilution

HSCS shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Apr 2021Jan 2026
Shares outstanding (latest)
3.2M
Since Apr 2021
+9442.7%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. HSCS20 data points from Apr 2021 to Jan 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about HSCS

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.